Advertisement

Endocrine Pathology

, Volume 12, Issue 2, pp 163–169 | Cite as

Correlation between PCNA expression and AgNOR dots in pituitary adenomas

  • Mariusz Klencki
  • Ilona Kurnatowska
  • Dorota Słowińska-Klencka
  • Andrzej Lewiński
  • Marek Pawlikowski
Clinical Research

Abstract

Nucleolar organizer regions are segments of DNA associated with argyrophilic proteins (AgNORs). Our previous findings showed that the number, the area, and the intranuclear localization of AgNOR dots differ according to tumor aggressiveness and to the hormone-immunopositivity of pituitary adenomas. Proliferating cell nuclear antigen (PCNA) is a nuclear protein, whose expression is correlated with cell proliferation. The aim of the present paper was to examine PCNA-labeling indexes in pituitary adenomas and to correlate them with AgNOR dots in various immunohistochemical types of the tumors.

Histological slides from 32 pituitary tumors and one normal pituitary were silver-stained and analyzed with a computerized system for microscopic image analysis. We found that the percentage of PCNA-positive cells did not differ significantly among examined groups of monohormonal adenomas. However, tumors immunopositive for α-subunit (α-SU) showed a significantly higher (p<0.05) PCNA index than adenomas immunonegative for that unit. PCNA index in recurrent tumors was significantly higher than in primary adenomas. There was a moderate positive correlation between the PCNA index and the mean area of AgNOR dots and a similar correlation between the PCNA index and the area of the biggest dot in the nucleus.

The obtained results reveal that the PCNA indexes and estimated parameters of AgNOR dots differ according to tumor aggressiveness.

Key Words

Pituitary adenoma PCNA nucleolar organizer regions immunohistochemistry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Derenzini M, Trere D. AgNOR proteins as a parameter of the rapidity of cell proliferation. Zentralbl Pathol 140:7–10, 1994.PubMedGoogle Scholar
  2. 2.
    Słowińska-Klencka D, Klencki M, Dedecjus M, Lewiński A, Pawlikowski M. Silver-staining nucleolar organizer region quantification in pituitary adenomas. Endocr Pathol 11:173–178, 2000.CrossRefGoogle Scholar
  3. 3.
    Hsu DW, Hakim F, Biller BM, de la Monte S, Zervas NT, Klibanski A, Hedley-Whyte ET. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 78:753–761, 1993.PubMedCrossRefGoogle Scholar
  4. 4.
    Chae YS, Flotte T, Hsu DW, Preffer F, Hedley-Whyte ET. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen. Gen Diagn Pathol 142:89–95, 1996.PubMedGoogle Scholar
  5. 5.
    Kawamoto H, Uozumi T, Kawamoto K, Arita K, Yano T, Hirohata T. Analysis of the growth rate and cavernous sinus invasion of pituitary adenomas. Acta Neurochir 136:37–43, 1995.CrossRefGoogle Scholar
  6. 6.
    Gandour-Edwards R, Kapadia SB, Janecka IP, Martinez AJ, Barnes L. Biologic markers of invasive pituitary adenomas involving the sphenoid sinus. Mod Pathol 8:160–164, 1995.PubMedGoogle Scholar
  7. 7.
    Atkin SL, Green VL, Hipkin LJ, Landolt AM, Foy PM, Jeffreys RV, White MC. A comparison of proliferation indices in human anterior pituitary adenomas using formalin-fixed tissue and in vitro cell culture. J Neurosurg 87:85–88, 1997.PubMedGoogle Scholar
  8. 8.
    Reitmaier M, Rudlowski C, Biesterfeld S, Rath W, Schroder W. Vergleichende untersuchungen zur biologischen bedeutung der proliferationsmarker Ki-67-antigen und PCNA in primaren ovarialkarzinomen. Zentralbl Gynakol 122:361–367, 2000.PubMedGoogle Scholar
  9. 9.
    Haitel A, Wiener HG, Migschitz B, Marberger M, Susani M. Proliferating cell nuclear antigen and MIB-1. An alternative to classic prognostic indicators in renal cell carcinomas? Am J Clin Pathol 107:229–235, 1997.PubMedGoogle Scholar
  10. 10.
    Trere D. Critical analysis of the methods commonly employed in the assessment of cell proliferation: advantages of the NOR silver-staining technique in routine cyto-histopathology. Anal Cell Pathol 5:191–201, 1993.PubMedGoogle Scholar
  11. 11.
    Ploton D, Menager M, Jeanneson P, Himber G, Pigeon F, Adnet JJ. Improvement in the staining and visualization of the argyrophilic proteins of the nucleolar organizer regions at the optical level. Histochem J 18:5–14, 1986.PubMedCrossRefGoogle Scholar
  12. 12.
    Howat AJ, Giri DD, Cotton DWK, Slater DN. Nucleolar organizer regions in Spitz nevi and malignant melanomas. Cancer 63:474–478, 1989.PubMedCrossRefGoogle Scholar
  13. 13.
    Ahiskali R, Alican Y, Ekicioglu G, Çevik I, Küllü S, Akdaş A. Evaluation of three different AgNOR counting methods in advanced carcinoma of the prostate. Prostate 26:105–110, 1995.PubMedCrossRefGoogle Scholar
  14. 14.
    Klencki M, Słowińska-Klencka D, Lewiński A. Quantitative analysis of argyrophilic nucleolar organising regions (AGNORs) with specialised Windows95/NT application. Computers in Medicine 5. ed. Polish Society of Medical Informatics. Vol. I:81–84, 1999.Google Scholar
  15. 15.
    Hufnagl P, Guski H, Schultz HJ. Measuring of AgNORs using image analysis. Zentralbl Pathol 140:31–35, 1994.PubMedGoogle Scholar
  16. 16.
    Turner HE, Wass JAH. Are markers of proliferation valuable in the histological assessment of pituitary tumours? Pituitary 1:147–151, 1999.PubMedCrossRefGoogle Scholar
  17. 17.
    Abe T, Sanno N, Osamura YR, Matsumoto K. Proliferative potential in pituitary adenomas: measurement by monoclonal antibody MIB-1. Acta Neurochir (Wien) 139:613–618, 1997.CrossRefGoogle Scholar
  18. 18.
    Daita G, Yonemasu Y. Dural invasion and proliferative potential of pituitary adenomas. Neurol Med Chir 36:211–214, 1996.CrossRefGoogle Scholar
  19. 19.
    Blevins LS Jr, Verity DK, Allen G. Aggressive pituitary tumors. Oncology 12:1307–1312, 1998.PubMedGoogle Scholar
  20. 20.
    Landolt AM, Shibata T, Kleihues P. Growth rate of human pituitary adenomas. J Neurosurg 67:803–806, 1987.PubMedGoogle Scholar
  21. 21.
    Knosp E, Kitz K, Perneczky A. Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery 25:927–930, 1989.PubMedCrossRefGoogle Scholar
  22. 22.
    Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38:99–106 (discussion 106–107), 1996.PubMedCrossRefGoogle Scholar
  23. 23.
    Schreiber S, Saeger W, Ludecke DK. Proliferation markers in different types of clinically non-secreting pituitary adenomas. Pituitary 1:213–220, 1999.PubMedCrossRefGoogle Scholar
  24. 24.
    Ghadially FN. Diagnostic electron microscopy of tumors. London: Butterworths, 1985; 19.Google Scholar
  25. 25.
    Montironi R, Braccischi A, Scarpelli M. Value of quantitative nucleolar features in the preoperative cytological diagnosis of follicular neoplasias of the thyroid. J Clin Pathol 44:509–514, 1991.PubMedCrossRefGoogle Scholar
  26. 26.
    Montironi R, Scarpelli M, Braccischi A. Quantitative analysis of nucleolar margination in diagnostic cytopathology. Virchows Arch A 419:505–512, 1991.CrossRefGoogle Scholar
  27. 27.
    Shibuya M, Saito F, Miwa T, Davis RL, Wilson CB, Hoshino T. Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Acta Neuropathol (Berl) 84:178–183, 1992.CrossRefGoogle Scholar
  28. 28.
    Pegolo G, Buckwalter JG, Weiss MH, Hinton DR. Pituitary adenomas. Correlation of the cytologic appearance with biologic behavior. Acta Cytol 39:887–892, 1995.PubMedGoogle Scholar
  29. 29.
    Szymas J, Hufnagl P, Liebert W. Invasive pituitary macroadenomas and nucleolar organizer region (AgNOR) counts. E J Pathol 981-07.txt, 1998.Google Scholar
  30. 30.
    Stefaneanu L, Horvath E, Kovacs K. Argyrophil organizer region (AgNORs) in adenohypophysial cells and adenomas of the human pituitary. Mod Pathol 1:192–199, 1989.Google Scholar

Copyright information

© Humana Press Inc 2001

Authors and Affiliations

  • Mariusz Klencki
    • 1
  • Ilona Kurnatowska
    • 2
  • Dorota Słowińska-Klencka
    • 1
    • 2
  • Andrzej Lewiński
    • 1
  • Marek Pawlikowski
    • 2
  1. 1.Department of Thyroidology, Institute of EndocrinologyMedical University of ŁódźPoland
  2. 2.Department of Experimental Endocrinology and Hormonal Diagnostics, Institute of EndocrinologyMedical University of ŁódźPoland

Personalised recommendations